Patients with glioblastoma, low grade glioma, liver hepatocellular carcinoma and acute myeloid leukemia, exhibiting higher expression of PON-2, had poor survival when compared with patients with lower PON-2 expression [195]. The gene discussed is PON2; the disease is central nervous system cancer.